Background Memory and cognitive impairments/disorders are the main clinical symptoms of
neurodegenerative diseases. The prevalence of such chronic conditions has increased over …

Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The worldwide effort to develop peptide …

Phototherapy, such as photodynamic therapy and photothermal therapy, holds great
potential for modulation of Alzheimer's β-amyloid (Aβ) self-assembly. Unfortunately, current …

Misfolded protein aggregates formed by the same (homologous) or different
(heterologous/cross) sequences are the pathological hallmarks of many protein misfolding …

Dysfunctional interaction of amyloid-β (Aβ) with excess metal ions is proved to be related to
the etiology of Alzheimer's disease (AD). Hence, disruption of these metal-peptide …

The Alzheimer's disease (AD) therapeutic research is yielding a large number of potent
molecules. The nanoparticle-based therapeutics against the protein aggregation in AD is …

Alzheimer's disease (AD) is a progressive neurodegenerative disease with no clinically
accepted treatment to cure or halt its progression. The Food and Drug Administration has …

Self-assembling peptides are being applied both in the biomedical area and as building
blocks in nanotechnology. Their applications are closely linked to their modes of self …

Prevention and therapeutic strategies for various neurodegenerative diseases focus on
inhibiting protein fibrillation, clearing aggregated protein plaques from the brain, and …

Peptidic biomaterials represent a particularly exciting topic in regenerative medicine.
Peptidic scaffolds can be specifically designed for biomimetic customization for targeted …